Literature DB >> 7502198

How to treat incidental cerebral aneurysms: a review of 139 consecutive cases.

K Mizoi1, T Yoshimoto, Y Nagamine, T Kayama, K Koshu.   

Abstract

BACKGROUND: Together with current advances in neuroimaging techniques, the chance of incidental discovery of unruptured cerebral aneurysms has increased and the selection of their appropriate management remains controversial. To provide current data about management results of patients with incidental cerebral aneurysms, we have made a retrospective review of 139 consecutive patients treated either by surgical or conservative means.
METHODS: The surgical indication for each patient was decided, carefully considering several factors respectively, including the surgical difficulty, aneurysm size, patient's age, and medical condition.
RESULTS: Forty-nine patients were managed conservatively. Eight (16%) of those conservatively managed patients had intracranial hemorrhage due to aneurysm rupture during the follow-up period (mean, 4.3 years). Seven of these eight patients died from a fatal subarachnoid hemorrhage (SAH). The follow-up data showed that the mean size of aneurysms with late hemorrhage was significantly larger than that of aneurysms without subsequent rupture. It was also confirmed that none of the 26 tiny aneurysms smaller than 4 mm in diameter had ruptured. Ninety patients harboring 119 incidental aneurysms less than 25 mm in diameter underwent surgery. There was no surgical mortality or morbidity in this series.
CONCLUSIONS: These excellent surgical results were presumably achieved due to the strict patient selection. In respect to the size of aneurysms, it seems to be justified to recommend surgery for patients with aneurysms larger than 5 mm in diameter.

Entities:  

Mesh:

Year:  1995        PMID: 7502198     DOI: 10.1016/0090-3019(95)00035-6

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  9 in total

Review 1.  Aggregate analysis of the literature for unruptured intracranial aneurysm treatment.

Authors:  Tony Lee; Michael Baytion; Robert Sciacca; J P Mohr; John Pile-Spellman
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

2.  Endovascular management of unruptured intracranial aneurysms: does outcome justify treatment?

Authors:  A J P Goddard; D Annesley-Williams; A Gholkar
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-04       Impact factor: 10.154

3.  Risk-benefit analysis of the treatment of unruptured intracranial aneurysms.

Authors:  R R Vindlacheruvu; A D Mendelow; P Mitchell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-02       Impact factor: 10.154

4.  Types of unruptured cerebral aneurysms reviewed from operation video-recordings.

Authors:  K Mizoi; T Yoshimoto; Y Nagamine
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

5.  Estimate of the maximum time interval between formation of cerebral aneurysm and rupture.

Authors:  P Mitchell; J Jakubowski
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-12       Impact factor: 10.154

6.  Risk analysis of treatment of unruptured aneurysms.

Authors:  P Mitchell; J Jakubowski
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-05       Impact factor: 10.154

7.  Endovascular coil embolization of 435 small asymptomatic unruptured intracranial aneurysms: procedural morbidity and patient outcome.

Authors:  S-H Im; M H Han; O-K Kwon; B J Kwon; S H Kim; J E Kim; C W Oh
Journal:  AJNR Am J Neuroradiol       Date:  2008-09-03       Impact factor: 3.825

8.  Size and location of ruptured intracranial aneurysms.

Authors:  Young-Gyun Jeong; Yong-Tae Jung; Moo-Seong Kim; Choong-Ki Eun; Sang-Hwan Jang
Journal:  J Korean Neurosurg Soc       Date:  2009-01-31

9.  A Meta-Analysis of Rupture Risk for Intracranial Aneurysms 10 mm or Less in Size Selected for Conservative Management Without Repair.

Authors:  Ronil V Chandra; Julian Maingard; Lee-Anne Slater; Nicholas K Cheung; Leon T Lai; Seana L Gall; Amanda G Thrift; Thanh G Phan
Journal:  Front Neurol       Date:  2022-02-17       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.